RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 154 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1 | 0.0% | 1,200 | 0.0% | 0.00% | – |
Q2 2023 | $1 | 0.0% | 1,200 | 0.0% | 0.00% | – |
Q1 2023 | $1 | 0.0% | 1,200 | 0.0% | 0.00% | – |
Q4 2022 | $1 | -99.9% | 1,200 | 0.0% | 0.00% | – |
Q3 2022 | $1,000 | 0.0% | 1,200 | 0.0% | 0.00% | – |
Q2 2022 | $1,000 | -66.7% | 1,200 | -52.0% | 0.00% | – |
Q1 2022 | $3,000 | 0.0% | 2,500 | -13.8% | 0.00% | – |
Q4 2021 | $3,000 | -25.0% | 2,900 | -68.1% | 0.00% | – |
Q3 2021 | $4,000 | -63.6% | 9,100 | +106.7% | 0.00% | -100.0% |
Q2 2021 | $11,000 | +120.0% | 4,403 | +51.8% | 0.00% | – |
Q1 2021 | $5,000 | -85.3% | 2,900 | -91.8% | 0.00% | -100.0% |
Q4 2020 | $34,000 | +1600.0% | 35,362 | +1864.6% | 0.00% | – |
Q3 2020 | $2,000 | -77.8% | 1,800 | -89.2% | 0.00% | – |
Q1 2019 | $9,000 | +50.0% | 16,700 | +70.4% | 0.00% | – |
Q4 2018 | $6,000 | -14.3% | 9,800 | 0.0% | 0.00% | – |
Q3 2018 | $7,000 | -61.1% | 9,800 | +84.9% | 0.00% | -100.0% |
Q1 2018 | $18,000 | +350.0% | 5,300 | -61.2% | 0.00% | – |
Q4 2016 | $4,000 | -71.4% | 13,675 | +1.3% | 0.00% | -100.0% |
Q3 2016 | $14,000 | – | 13,500 | +6650.0% | 0.00% | – |
Q2 2016 | $0 | – | 200 | 0.0% | 0.00% | – |
Q1 2016 | $0 | – | 200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 9,105,691 | $30,140,000 | 5.99% |
Sio Capital Management, LLC | 1,888,181 | $6,250,000 | 3.50% |
DAFNA Capital Management LLC | 473,478 | $1,567,000 | 1.32% |
Cormorant Asset Management, LP | 2,000,000 | $6,620,000 | 0.96% |
Ghost Tree Capital, LLC | 1,100,000 | $3,641,000 | 0.68% |
Rhenman & Partners Asset Management AB | 1,282,000 | $4,243,000 | 0.67% |
Palo Alto Investors LP | 4,254,623 | $14,083,000 | 0.67% |
NEA Management Company, LLC | 3,243,150 | $10,375,000 | 0.36% |
Telemetry Investments, L.L.C. | 170,000 | $563,000 | 0.25% |
NJ State Employees Deferred Compensation Plan | 355,000 | $1,175,000 | 0.22% |